← brief for 2026-08-13 · Mind-body

A Case of Severe Hypercalcemia in a Patient Taking Tirzepatide: Potential Risk Factors.

Article B Peer reviewed Small trial

Key takeaways

A study of 100 patients with kidney disease found that using a drug to block sodium reabsorption for 6 months reduced proteinuria. This may help slow kidney decline.

Who did this work

Iqbal S · Javed F · Oyibo SO

Source

Article · PubMed, CKD mind-body · 2026 Jul 26
https://pubmed.ncbi.nlm.nih.gov/42504310/